Lipoprotein(a) and lipid profile in patients with atrial fibrillation

Medical Science Monitor

Volumn 12, Issue 3, 2006, Pages

  Díaz Peromingo, José Antonio ^a,b   Albán Salgado, Ana ^a   García Suárez, Florinda ^a   Sánchez Leira, Joaquín ^a   Saborido Froján, Juan ^a   Iglesias Gallego, Marina ^a  

^a Hospital da Barbanza   (Spain)

^b NONE   (Spain)

Author keywords

Atrial fibrillation; Lipid profile; Lp(a)

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; SPAIN;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; RISK FACTORS; TRIGLYCERIDES;

EID: 33644683377     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mitchell A: Atrial fibrillation in the new millenium: the role of pacemaker and defibrillator therapy. Med Sci Monit, 2002; 8(10): RA233-RA239
2. Iragashi Y, Yamamura M, Ito M et al: Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophageal echocardiographic study. Am Heart J, 1998; 136(6): 965-71
3. Caplice NM, Panetta C, Peterson TE et al: Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood, 2001; 98(10): 2980-87
4. Celik S, Baykan M, Orem C et al: Serum lipoprotein(a) and its relation to left ventricular thrombus in patients with acute myocardial infarction. Jpn Heart J, 2001; 42(1): 5-14
5. Iragashi Y, Kasai H, Yamashita F et al: Lipoprotein(a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J, 2000; 64(2): 93-98
6. Van Kooten F, Van Krimpen J, Dippel DW et al: Lipoprotein(a) in patients with acute cerebral ischemia. Stroke, 1996; 27(7): 1231-35
7. Shintani S, Kikuchi S, Hamaguchi H, Shiigai T: High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Stroke, 1993; 24(7): 965-69
8. Jamieson DG, Fu L, Usher DC, Lavi E: Detection of lipoprotein(a) in intraparenchymal cerebral vessels: correlation with vascular pathology and clinical history. Exp Mol Pathol, 2001; 71(2): 99-105
9. Fu L, Jamieson DG, Usher DC, Lavi E: Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries. Atherosclerosis. 2001; 158(2): 303-11
10. Katsouras CS, Karabina SA, Tambaki AP et al: Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease. J Cardiovasc Risk, 2001; 8(5): 311-17
11. Efthimiadis A, Lefkos N, Psirropoulos D et al: Risk factors of ischaemic heart disease and long-term outcome after coronary bypass surgery. J Cardiovasc Surg (Torino), 2001; 42(6): 731-34
12. Lloyd GW, Jackson G, Foley DP et al: The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty. Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial. Atherosclerosis, 2001; 158(2): 445-54
13. Lippi G, Arosio E, Prior M, Guidi G: Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens. Angiology, 2001; 52(10): 681-87
14. Klezovitch O, Edelstein C, Scanu AM: Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein (a): evidence for a critical involvement of elements in its C-terminal domain. J Biol Chem, 2001; 276(50): 46864-69
15. Pietrzak B, Pietrzak A, Lecewicz-Torun B: Serum apolipoprotein A concentration in psoriatic male patients. Med Sci Monit, 1996; 2(3): 278-81
16. Martínez C, Rivera J, Loyau S et al: Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation. Thromb Haemost, 2001; 85(4): 686-93
17. Matthews KA, Sowers MF, Derby CA et al: Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J, 2005; 149(6): 1066-73
18. Lee TC, O'Malley PG, Feuerstein I, Taylor AJ: The prevalence and severity of coronary artery calci. cation on coronary artery computed tomography in black and white subjects. J AM Coll Cardiol, 2003; 41(1): 39-44
19. Hajat C, Tilling K, Stewart JA et al: Ethnic differences in risk factors for ischemic stroke: a European case-control study. Stroke, 2004; 35(7): 1562-67
20. Conway DS, Lip GY: Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). Am J Cardiol, 2003; 92(12): 1476-79
21. Sacco RL, Boden-Albala B, Abel G et al: Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke, 2001; 32(8): 1725-31
22. Kim H, Marcovina SM, Edwards KL et al: Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia. Clin Genet, 2001; 60(3): 188-97
23. Scanu AM: The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events. Curr Cardiol Rep, 2001; 3(5): 385-90